Mixed Connective Tissue Disease: Clinical Trials

5 trials for Mixed Connective Tissue Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 recruiting. 5 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Terminated 2, Recruiting 1
Phase 33Completed 2, Terminated 1

Follow Mixed Connective Tissue Disease: new trials by email Literature Review of Mixed Connective Tissue Disease trials Research Report on Mixed Connective Tissue Disease

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intralesional Injection of STS in Treatment of Calcinosis
Sodium Thiosulfate (STS) - Systemic Sclerosis (SSc), Dermatomyositis
Phase 2RecruitingRobyn T. Domsic, MD, MPH202025-03-172026-05-05
A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)
MHV370, Placebo - Sjogren Syndrome, Mixed Connective Tissue Disease
Phase 2TerminatedNovartis Pharmaceuticals302021-11-302024-10-09
Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Rituximab, Cyclophosphamide - Interstitial Lung Disease, Scleroderma
Phase 2 / Phase 3CompletedRoyal Brompton & Harefield NHS Foundation Trust1042014-11-012021-10-07
A Clinical Trial for CTD-ILD Treatment
N-Acetylcysteine - Interstitial Lung Disease, Connective Tissue Disease
Phase 2 / Phase 3TerminatedUniversity of Michigan52011-12-012017-04-06
Alendronate Osteoporosis Study
Alendronate - Glucocorticoid-Associated Osteopenia and Osteoporosis
Phase 2 / Phase 3CompletedBoston Children's Hospital202003-03-012017-04-11

Narrower conditions

Dermatomyositis (4)  ·  Connective Tissue Diseases (2)  ·  Lung Diseases, Interstitial (2)  ·  Polymyositis (2)  ·  Scleroderma, Diffuse (2)  ·  Sjogren's Syndrome (2)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Rheumatoid (1)  ·  Calcinosis (1)  ·  Crohn Disease (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Myositis (1)  ·  Osteoporosis (1)  ·  Pulmonary Fibrosis (1)

Broader conditions

Musculoskeletal Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Muscular Diseases (4)  ·  Nervous System Diseases (4)  ·  Neuromuscular Diseases (4)  ·  Skin Diseases (4)  ·  Arthritis (3)  ·  Autoimmune Diseases (3)  ·  Connective Tissue Diseases (3)  ·  Immune System Diseases (3)  ·  Joint Diseases (3)  ·  Myositis (3)  ·  Rheumatic Diseases (3)  ·  Dry Eye Syndromes (2)  ·  Eye Diseases (2)

Interventions

Acetylcysteine (1)  ·  Alendronate (1)  ·  Cyclophosphamide (1)  ·  Rituximab (1)  ·  sodium thiosulfate (1)

Sponsors

Boston Children's Hospital (1)  ·  Novartis Pharmaceuticals (1)  ·  Robyn T. Domsic, MD, MPH (1)  ·  Royal Brompton & Harefield NHS Foundation Trust (1)  ·  University of Michigan (1)

Countries

United States (2)  ·  China (1)  ·  Germany (1)  ·  Hungary (1)  ·  Poland (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Catherine Gordon, MD (1)  ·  Robyn T Domsis, MD (1)  ·  Toby M Maher, MD PhD (1)

Results publications

PMID 15942915, PMID 22227955, PMID 28619061, PMID 36375479, PMID 40747756, PMID 40787733

NIH funding

P50AR080612 (1)